Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Ensysce Biosciences Inc
ENSCCurrent price
0.33 USD
-0.0099 USD (-2.91%)
Last closed
0.35 USD
Company
www.ensysce.com
ISIN
US2936021086
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 874 446 USD
Yield for 12 month
-80.22 %
1Y
3Y
5Y
10Y
15Y
ENSC
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection (TAAP) platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance (MPAR) platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP oxycodone prodrug candidate for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF614, an extended-release oxycodone-derivative that releases clinically effective oxycodone; PF329 for pain with abuse protection; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD; and PF9001 to treat Opioid use disorder. The company was founded in 2003 and is based in La Jolla, California. Address: 7946 Ivanhoe Avenue, La Jolla, CA, United States, 92037
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8.3 USDP/E ratio
–Dividend Yield
–Current Year
+2 230 520 USD
Last Year
+2 523 380 USD
Current Quarter
+181 797 USD
Last Quarter
+305 722 USD
Current Year
-5 356 953 USD
Last Year
-17 312 492 USD
Current Quarter
+181 797 USD
Last Quarter
+305 722 USD
Key Figures ENSC
1 year
3 years
5 years
10 years
EBITDA
-24 221 944 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-131.94 %
PEG Ratio
–
Return On Equity TTM
-427.89 %
Wall Street Target Price
8.3 USD
Revenue TTM
1 437 932 USD
Book Value
0.22 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-62.9 %
Dividend Yield
–
Gross Profit TTM
-1 158 883 USD
Earnings per share
-2.7 USD
Diluted Eps TTM
-2.7 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ENSC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ENSC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
31.03.2023
Dividend Date
–
Stock Valuation ENSC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
1.999
Enterprise Value EBITDA
-0.5014
Price Book MRQ
1.59
Financials ENSC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ENSC
For 52 weeks
0.31 USD
2.06 USD
50 Day MA
0.42 USD
Shares Short Prior Month
17 306
200 Day MA
0.75 USD
Short Ratio
0.15
Shares Short
689 389
Short Percent
7.98 %
BeatStart